| Literature DB >> 27226509 |
Abstract
Survival of patients with metastatic colorectal cancer has dramatically improved over the past 20 years, primarily because physicians have become adept at using the many regimens approved for this patient population. Future advances may come from understanding molecular subtypes, finding and treating new actionable mutations, and harnessing the immune system.Entities:
Mesh:
Year: 2016 PMID: 27226509 DOI: 10.6004/jnccn.2016.0187
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN: 1540-1405 Impact factor: 11.908